NASDAQ:URGN | EBITDA Margin | UroGen Pharma Ltd.

Complete source-backed ebitda margin history.

Available history
2016-12-31 to 2026-06-30
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2026-06-300.29%
2026-03-31-39.62%
2025-12-31-50.32%
2025-09-30-99.29%
2025-06-30-170.75%
2025-03-31-181.90%
2024-12-31-112.31%
2024-09-30-69.22%
2024-06-30-117.81%
2024-03-31-136.40%
2023-12-31-61.28%
2023-09-30-63.78%
2023-06-30-71.82%
2023-03-31-126.97%
2022-12-31-110.80%
2022-09-30-111.12%
2022-06-30-111.51%
2022-03-31-160.29%
2021-12-31-121.81%
2021-09-30-204.74%
2021-06-30-173.60%
2021-03-31-346.33%
2020-12-31-340.61%
2020-09-30-838.60%
2020-06-30-8521.51%
2019-06-30-131405.56%
2018-09-30-7416.61%
2018-06-30-5051.23%
2018-03-31-2794.18%

Annual EBITDA Margin

DateEBITDA Margin
2025-12-31-113.45%
2024-12-31-106.70%
2023-12-31-78.26%
2022-12-31-121.38%
2021-12-31-190.38%
2020-12-31-1070.62%
2019-12-31-606544.44%
2018-12-31-6806.74%
2017-12-31-242.09%
2016-12-315.69%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.